Alterations in the gut microbiome of children with severe ulcerative colitis - Wikidata - wikimedia - TriplyDB

Alterations in the gut microbiome of children with severe ulcerative colitis

Alterations in the gut microbiome of children with severe ulcerative colitis

http://www.wikidata.org/entity/Q34101549

about

Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection Inflammatory bowel disease as a model for translating the microbiome The intestinal microbiome in early life: health and disease Upper gastrointestinal microbiota and digestive diseases Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease Tiny microbes, enormous impacts: what matters in gut microbiome studies?Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood Human microbiota-associated swine: current progress and future opportunities Gut Microbiome of an 11th Century A.D. Pre-Columbian Andean Mummy Host genetic variation impacts microbiome composition across human body sites Transitioning From Descriptive to Mechanistic Understanding of the Microbiome: The Need for a Prospective Longitudinal Approach to Predicting Disease High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.Novel device to sample the esophageal microbiome--the esophageal string test.Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.Microbial ecosystems therapeutics: a new paradigm in medicine?From molecules to dynamic biological communities.Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease.Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats.Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease Inoculum selection is crucial to ensure operational stability in anaerobic digestion.IBD and the gut microbiota--from bench to personalized medicine.Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis Encyclopedia of bacterial gene circuits whose presence or absence correlate with pathogenicity--a large-scale system analysis of decoded bacterial genomes Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.The microbiome and childhood diseases: Focus on brain-gut axis.A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem?Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases.Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease.Maintenance of gut homeostasis by the mucosal immune system.Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.

P2860

Q21284481-E593B5C4-754F-4D4C-A226-AFB97602300C Q26745700-33650C23-DA81-4B3C-ACFD-329053869BA6 Q26765893-278F7C73-F199-4585-8A90-E7362D46B033 Q26774688-A298DB75-E5C1-41C4-AB22-E5AD6A93E111 Q26853123-D24DF1E2-3BA1-4C99-A4B1-9134877491BD Q26996343-7A183D63-D716-4A5A-98E1-F0983C5CADAB Q27002380-0D63FD3F-6905-4E66-A410-55BCCF85FD86 Q27003192-2DB3F4AC-4C7E-4314-A88D-0D3F4F158BC0 Q28066755-507CCD85-7951-43CC-BE09-FE94C9D7026F Q28070349-0FF08216-1504-4E22-9459-B520AF6608A6 Q28075770-B4ABB02D-0B45-4F3E-8CD4-3D4358AC8FFA Q28084906-9C9C54FC-73B4-4A61-A63E-917DA3312850 Q28548686-4B82B2A5-EB3D-4C79-B9FD-4B1BA296D240 Q28607663-B301E6A6-2765-46FE-B52D-5B0D228EEA01 Q33822244-1D9182E7-A56B-492F-9C84-D750575B24FC Q33835890-0B89C5E1-AB45-4FCC-B437-6126A83996A9 Q33879834-696FA849-B591-42B7-BC70-F50F81B2008D Q34042017-C6B9F612-741B-4DFB-B5D0-4204F4B497F4 Q34407947-4D8643F3-924D-4859-BD1B-54DEB8575E65 Q34499080-3F9A8E64-3DBE-47FA-8A1B-F713AF611C6D Q34519313-955FDE4C-451B-4261-AEFF-AF4E071E5B54 Q34617965-C67322F6-96F3-465E-A4A0-338427E1EC51 Q35044905-8EF7AD34-D596-4525-9350-649B3218BA8C Q35102353-0672DF55-6559-4DC1-BF97-F4B3E64F20B4 Q35174451-81275611-5CB3-4F54-AB54-0CBCBEB218A0 Q35281110-0E9B8B56-F7DD-4840-A123-0C3BB2422BF5 Q35575495-4607B083-EB08-4651-B010-495729F3017C Q35634488-7E0FACB4-8065-437C-B3F2-46BE2D75A535 Q35748693-88EB3C2F-087E-411C-B1FB-A5DDF0676726 Q35750427-407D0DC5-DD29-475C-9B73-D77A732675EF Q35804215-61BD85F1-7BC8-4411-888D-10D90F6C8D1D Q35867610-AA0040DA-BD95-47C9-B2B4-5AAD002458DF Q35878852-60E6DB0E-A02E-4B39-8C05-AA02F9AF0813 Q35973766-7C7E5C28-6AD8-4923-8AE6-C15484859E30 Q35986057-BD309886-A03E-4E3C-8CB5-0B6EC399399B Q35997779-155C942F-9658-4AA6-9AEF-574DA62661E7 Q36175670-70F44F39-BA89-4BF7-AA66-013A0EC897F7 Q36180180-0E8F1039-7D74-4E14-B14A-22E0E65E8B74 Q36191293-94A08388-516D-4B24-8C45-91DC79D230CA Q36310672-A014CB3A-24B4-45EA-8CC7-BC0DA8C8ECEB

P2860

Alterations in the gut microbiome of children with severe ulcerative colitis

http://www.wikidata.org/entity/Q34101549

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Alterations in the gut microbiome of children with severe ulcerative colitis

@ast

Alterations in the gut microbiome of children with severe ulcerative colitis

@en

Alterations in the gut microbiome of children with severe ulcerative colitis

@nl

type

label

Alterations in the gut microbiome of children with severe ulcerative colitis

@ast

Alterations in the gut microbiome of children with severe ulcerative colitis

@en

Alterations in the gut microbiome of children with severe ulcerative colitis

@nl

prefLabel

Alterations in the gut microbiome of children with severe ulcerative colitis

@ast

Alterations in the gut microbiome of children with severe ulcerative colitis

@en

Alterations in the gut microbiome of children with severe ulcerative colitis

@nl

P1433

Q34101549-F9DC2769-1AC1-4F48-916D-E02E6343A281

P1476

Q34101549-C3CC9E85-36A1-4AEB-BF16-22A79487AD11

P2093

Q34101549-0532DA4B-01D7-4BF8-9ECD-AEC977384B5A

Q34101549-0A3A810F-E45F-4AD9-AD52-70387F5F3DC5

Q34101549-16ED99CE-2371-4928-852E-5F01C0463AFA

Q34101549-1D53F2D9-A921-4E9D-88C2-E8B9DD524E9B

Q34101549-2B3A738E-5B57-4D3E-8DE7-6EE173E2032E

Q34101549-624D802E-9E40-46EC-A529-A9B591C7D74C

Q34101549-87377E11-AD0D-4DD4-9EEA-FA1C552EA88A

Q34101549-9FEC589E-DC01-4DE1-B77E-1D27A1EA3529

Q34101549-AAD6A153-5C19-4046-B1CF-FD60D52B2EEC

P2860

Q34101549-031E3DB9-D983-4770-B448-6D6BA283ED76

Q34101549-0992F680-22EC-4C78-9238-632F98C718B7

Q34101549-0C1A2A0E-5A2F-4F6F-9603-8C7EC3308B44

Q34101549-0CECA108-903D-464E-BCCC-E7E79DDC0792

Q34101549-150E8B11-DF23-4D5C-B9AF-E45B55697927

Q34101549-15F40144-7EB5-48AB-9FCC-9B2540BFACFC

Q34101549-1DAE2A79-8546-4EC1-AAA8-75865150FEDE

Q34101549-1DB647D3-977D-4595-9FEB-F99E8FEE1836

Q34101549-2351C88D-8F4A-48ED-8621-42B1047FE2EB

Q34101549-239BF086-241D-452C-9FB0-6D2B18F46997

P304

Q34101549-E8423201-D19A-4449-A91D-F060DE2CE391

P31

Q34101549-4533AC02-C9EB-4B78-B538-B2971CD13E1C

P356

Q34101549-7C36CF91-A8DE-4814-8C87-6478F3833AFF

P433

Q34101549-1D05534A-C6DB-4A1E-A266-61F0E4CD04AE

P478

Q34101549-205BD580-903D-4921-91BF-086E2BB3B872

P50

Q34101549-73757156-0973-4BAF-AFA7-3B63FE5ED756

P577

Q34101549-C3F710F3-E68F-450B-9EDA-195718A78BDA

P5875

Q34101549-D586FFBB-4E16-4970-8408-385B9FA560C3

P698

Q34101549-FC2B258F-5240-4E97-93A2-E207960D2203

P921

Q34101549-64C0556D-6EB2-4D96-9E6D-0C17472284B9

P932

Q34101549-BA4EF1DF-47D5-4720-BFAF-5BAAD5D77267

P356

P1433

Inflammatory Bowel Diseases

P1476

Alterations in the gut microbiome of children with severe ulcerative colitis

@en

P2093

Adrienne Stolfi

http://www.w3.org/2001/XMLSchema#string

Anne M Griffiths

http://www.w3.org/2001/XMLSchema#string

Dan Turner

http://www.w3.org/2001/XMLSchema#string

David R Mack

http://www.w3.org/2001/XMLSchema#string

Eytan Wine

http://www.w3.org/2001/XMLSchema#string

Harshavardhan Kenche

http://www.w3.org/2001/XMLSchema#string

Jeffrey Hyams

http://www.w3.org/2001/XMLSchema#string

Matthew Durbin

http://www.w3.org/2001/XMLSchema#string

Sonia Michail

http://www.w3.org/2001/XMLSchema#string

P2860

Antibiotics and probiotics in inflammatory bowel disease: why, when, and how

Adherent-invasive Escherichia coli and Crohnʼs disease

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Metagenomic analysis of the human distal gut microbiome

The NIH Human Microbiome Project

Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease

Dysbiosis in inflammatory bowel disease

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

Commensal host-bacterial relationships in the gut

P304

1799-1808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.22860

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51880868

http://www.w3.org/2001/XMLSchema#string

P698

22170749

http://www.w3.org/2001/XMLSchema#string

P921

P932

3319508

http://www.w3.org/2001/XMLSchema#string